Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Wuzi Yanzong Pill improves Parkinson's disease via miR-146a-5p/USP3/NF-κB axis.
Unmet needs in the care of patients with neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody associated disease: insights from Germany.
Regulation of oligodendrocyte metabolism and myelination by acetyl-L-carnitine in a mouse model of post-weaning social isolation.
Extracellular Space Barrier Dysfunction Disrupts Interstitial Fluid Drainage and Is Associated with Memory Heterogeneity in Cognitive Aging.
[The era of precision diagnosis and treatment for optic neuritis: advances in diagnostic classification, biomarkers and therapeutic strategies].
Spinal cord transverse section hinders Wallerian degeneration and neoangiogenesis after peripheral nerve transection: Involvement of Schwann cells' miR-134-5p.
Missed radiologic disease activity by conventional side-by-side MRI comparison is associated with future disease activity in multiple sclerosis: Adopting semiautomated coregistration-fusion into clinical practice.
The many faces of the multiple sclerosis population in Canada.
Heterocyclic Scaffolds as Therapeutic Agents in Multiple Sclerosis: Mechanisms and SAR Study.
Weight-adjusted adenosine and first-dose conversion success in supraventricular tachycardia: a prospective cohort study.
Ferroptosis of microvascular pericytes contributes to ischemia-reperfusion injury in mice.
Preventing frailty in multiple sclerosis is a realistic goal - No.
Assessment of treatment response in recurrent medulloblastoma using craniospinal MRI.
Gastrointestinal Diagnoses and Symptoms in Medicare Patients With Neuropsychiatric Diseases.
Genetically predicted association between immune cells and optic neuritis: evidence from a Mendelian randomization study.
The Case | Podocyte vacuolization and myelin figures in a young male with proteinuria.
Genetically predicted vitamin D levels and risk of head and neck cancer: a mendelian randomization study.
A dried blood spot protocol for high-throughput semi-quantitative analysis of Epstein-Barr Virus VCA IgG and EBNA IgG serologies based on the Roche Elecsys system.
Correction to "Lessons Learned: Quality Analysis of Optical Coherence Tomography in Neuromyelitis Optica".
Artificial Intelligence Applications to Support Physical Activity, Mobility, and Fatigue Management in People with Multiple Sclerosis: A Scoping Review.
The COMPASS-MS Study on Implementing Digital Assessment and Treatment for Psychological Distress in Patients With Multiple Sclerosis: Protocol for a Real-World Longitudinal Study.
Comment on "Circulatory immune cell counts and clinical outcomes in multiple sclerosis relapse versus remission".
Diffuse cauda equina nerve root enlargement: diagnostic challenges, clinicopathological spectrum, and the role of surgical biopsy.
MRI-based oxygen extraction fraction mapping using qBOLD, QSM, and hybrid QSM-qBOLD methods: Methodological advances, validation, and clinical applications.
Therapeutic potential of spirulina and its bioactive compound phycocyanin in neuropsychiatric disorders.
Pages
« first
‹ previous
…
1031
1032
1033
1034
1035
1036
1037
1038
1039
…
next ›
last »